TGH Cancer Institute Earns Prestigious QOPI® Certification
Recognized for its unwavering commitment to quality care, the TGH Cancer Institute has achieved QOPI® certification, a significant milestone established by the American Society of Clinical Oncology (ASCO). This accolade highlights a culture of excellence aimed at enhancing patient outcomes and safety standards in oncology.
A Testament to Quality Oncology Care
The QOPI® certification acknowledges hospitals that meet rigorous standards in cancer care. TGH is proud to demonstrate exceptional performance in various critical areas, including treatment planning, staff training, patient consent, and chemotherapy administration. This certification exemplifies a commitment not only to national standards but also to continuous improvement in oncology practices.
Leadership That Makes a Difference
Dr. Eduardo Sotomayor, vice president and executive director of the TGH Cancer Institute, emphasizes the collaborative effort behind this achievement. "This accreditation elevates our compassionate oncology care to another level and underscores how we foster a culture of excellence that enhances our ability to deliver world-class care to our patients," he stated. Esteemed team members such as Tricia Skarr, MSN, RN, ONC, and Leo Begazo, RN, were instrumental in guiding the institute through this rigorous evaluation, leading to its successful certification.
Commitment to Comprehensive Cancer Treatment
TGH Cancer Institute's accomplishment stems from its dedication to comprehensive oncology services. The institute excels in chemotherapy orders, drug preparation, safe administration techniques, and monitoring patient well-being. These core standards form the foundation of the high-quality care the institute delivers.
Renewal and Future Prospects
A notable aspect of the QOPI® certification is its renewable nature, with TGH set to maintain its certification through 2027. This renewal process ensures ongoing adherence to quality standards and a commitment to refining cancer care practices.
Recognizing Partnerships for Enhanced Care
Furthermore, the collaboration with the USF Health Morsani College of Medicine ensures that TGH Cancer Institute has access to the latest medical advances and comprehensive cancer care solutions, encompassing all areas of oncology, including surgical services and hematology. This alignment facilitates a multidisciplinary approach to patient care.
Innovative Patient Care Models
Surveyors noted the effectiveness of TGH's Care Coordination Center, designed to streamline workflows and enhance patient tracking throughout the hospital, significantly benefiting patients with critical conditions such as leukemia. This innovation exemplifies the hospital's commitment to timely and effective care delivery.
Reputation Among the Best
The recognition from ASCO places TGH Cancer Institute among the leading cancer facilities nationwide. It is essential to highlight that TGH ranks among the top 50 cancer centers in U.S. News & World Report's 2024-2025 Best Hospitals, reflecting the institution's excellence in medical care. Additionally, it has garnered accolades from the American College of Surgeons, solidifying its reputation as a center of excellence in oncology.
Community Impact through Comprehensive Care
TGH not only provides exceptional cancer treatment but also serves a vital role in the community by addressing healthcare disparities and offering comprehensive education and support to patients. The hospital's commitment to community health, including a net benefit of over $240 million in care for underinsured patients, showcases its dedication to accessible healthcare.
Frequently Asked Questions
What is QOPI® certification?
QOPI® certification is an acknowledgment of oncology practices that meet specific quality care standards established by ASCO.
How often is QOPI® certification renewed?
The certification is renewed every three years, allowing practices to continuously improve their standards.
What areas of care does TGH excel in?
TGH excels in treatment planning, staff training, chemotherapy preparation, and monitoring patient outcomes.
Who leads the TGH Cancer Institute?
Dr. Eduardo Sotomayor serves as the vice president and executive director, supported by a dedicated leadership team.
How does TGH impact the community?
TGH supports community health through substantial benefits, educational programs, and by providing care regardless of patients' ability to pay.
